MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances

Hongyun Mao, Jing Hu, Chenshuo Yu, Sicong Xie, Cheng Chang, Juanjuan Peng, Yang Zhang

Open source

DOI
10.3389/fcvm.2025.1614878
Published
2025-08-22
Container
Frontiers in Cardiovascular Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2025.1614878,
  title = {MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances},
  author = {Hongyun Mao and Jing Hu and Chenshuo Yu and Sicong Xie and Cheng Chang and Juanjuan Peng and Yang Zhang},
  year = {2025},
  journal = {Frontiers in Cardiovascular Medicine},
  doi = {10.3389/fcvm.2025.1614878},
  url = {https://doi.org/10.3389/fcvm.2025.1614878}
}

RIS

TY  - JOUR
TI  - MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances
AU  - Hongyun Mao
AU  - Jing Hu
AU  - Chenshuo Yu
AU  - Sicong Xie
AU  - Cheng Chang
AU  - Juanjuan Peng
AU  - Yang Zhang
PY  - 2025
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2025.1614878
UR  - https://doi.org/10.3389/fcvm.2025.1614878
ER  - 

APA

Mao, H., Hu, J., Yu, C., Xie, S., Chang, C., Peng, J., & Zhang, Y. (2025). MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2025.1614878

Source records